Journal ArticleAm Heart J · October 2024
BACKGROUND: Our objective was to determine the number of major cardiovascular events (MACE, nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death) and deaths from any cause that could be prevented across varying nationwide uptake of sema ...
Full textLink to itemCite
Journal ArticlePatient Educ Couns · July 31, 2024
Relative to the rapid increase in available health information, little has been published on the differential impact misinformation has on the health of communities. Observations during the height of the COVID-19 pandemic indicated there were communities t ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Geriatr Soc · May 26, 2024
Beta amyloid PET scans are a minimally invasive biomarker that may inform Alzheimer's disease (AD) diagnosis. The Caregiver's Reactions and Experience (CARE) study, an IDEAS supplement, aimed to understand experiences of PET scan recipients and their care ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · March 2024
BACKGROUND: The Imaging Dementia Evidence for Amyloid Scanning (IDEAS) study reports that amyloid PET scans help providers diagnose and manage Alzheimer's disease and related dementias (ADRD). Using CARE-IDEAS, an IDEAS supplemental study, we examined the ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · February 2024
The NIH Pragmatic Trials Collaboratory supports the design and conduct of 27 embedded pragmatic clinical trials, and many of the studies collect patient reported outcome measures as primary or secondary outcomes. Study teams have encountered challenges in ...
Full textLink to itemCite
Journal ArticleJ Alzheimers Dis · 2024
BACKGROUND: Elevated amyloid-β (Aβ) on positron emission tomography (PET) scan is used to aid diagnosis of Alzheimer's disease (AD), but many prior studies have focused on patients with a typical AD phenotype such as amnestic mild cognitive impairment (MCI ...
Full textLink to itemCite
Journal ArticlePLoS One · 2024
COVID-19 increased the prevalence of clinically significant anxiety in the United States. To investigate contributing factors we analyzed anxiety, reported online via monthly Generalized Anxiety Disorders-7 (GAD-7) surveys between April 2020 and May 2022, ...
Full textLink to itemCite
Journal ArticleRes Gerontol Nurs · 2024
PURPOSE: To understand nursing home workers' experience during the coronavirus disease 2019 (COVID-19) pandemic and investigate the prevalence of health-related quality of life, emotional distress, job satisfaction, and the impact of the pandemic. METHOD: ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 10, 2023
Background Cardiovascular disease (CVD) disproportionately affects Black adults. Greater social networks (SNs), or social connectedness, may lower the risk of CVD events. This study determined the association of SNs and incident CVD and tested mediation by ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · October 1, 2023
Sacubitril/valsartan improves outcomes in patients with heart failure with reduced ejection fraction (HFrEF) compared with angiotensin-converting enzyme inhibitors (ACEis). However, data on postdischarge outcomes in renin-angiotensin system inhibitor (RASi ...
Full textLink to itemCite
Journal ArticleJMIR Med Inform · August 22, 2023
BACKGROUND: Throughout the COVID-19 pandemic, many hospitals conducted routine testing of hospitalized patients for SARS-CoV-2 infection upon admission. Some of these patients are admitted for reasons unrelated to COVID-19 and incidentally test positive fo ...
Full textLink to itemCite
Journal ArticleJ Am Med Inform Assoc · August 18, 2023
Embedded pragmatic clinical trials (ePCTs) play a vital role in addressing current population health problems, and their use of electronic health record (EHR) systems promises efficiencies that will increase the speed and volume of relevant and generalizab ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · July 2023
Embedded pragmatic clinical trials (ePCTs) are conducted during routine clinical care and have the potential to increase knowledge about the effectiveness of interventions under real world conditions. However, many pragmatic trials rely on data from the el ...
Full textLink to itemCite
Journal ArticleJMIR Med Inform · June 17, 2023
BACKGROUND: Throughout the COVID-19 pandemic, many hospitals conducted routine testing of hospitalized patients for SARS-CoV-2 infection upon admission. Some of these patients are admitted for reasons unrelated to COVID-19, and incidentally test positive f ...
Full textLink to itemCite
ConferenceAm J Prev Cardiol · June 2023
OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease, yet little is known about Lp(a) testing patterns in real-world practice. The objective of this analysis was to determine how Lp(a) testing is used in clin ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · June 2023
INTRODUCTION: Racial/ethnic disparities exist in many aspects of health care, but data on racial/ethnic disparities for neurodegenerative diseases (NDDs), such as dementia and Parkinson's disease (PD), are limited. METHODS: We used North and South Carolina ...
Full textLink to itemCite
Journal ArticlePrev Med · May 2023
Whether individuals in real-world settings are able to lose weight and improve cardiometabolic risk factors over time is unclear. We aimed to determine the management of and degree of body weight change over 2 years among individuals with overweight or obe ...
Full textLink to itemCite
Journal ArticleJ Hypertens · May 1, 2023
OBJECTIVE: We aimed to characterize seasonal variation in US population-based blood pressure (BP) control and BP-related metrics and evaluate the association between outdoor temperature and BP control variation. METHODS: We queried electronic health record ...
Full textLink to itemCite
Journal ArticleAm Heart J · October 2024
BACKGROUND: Our objective was to determine the number of major cardiovascular events (MACE, nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death) and deaths from any cause that could be prevented across varying nationwide uptake of sema ...
Full textLink to itemCite
Journal ArticlePatient Educ Couns · July 31, 2024
Relative to the rapid increase in available health information, little has been published on the differential impact misinformation has on the health of communities. Observations during the height of the COVID-19 pandemic indicated there were communities t ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Geriatr Soc · May 26, 2024
Beta amyloid PET scans are a minimally invasive biomarker that may inform Alzheimer's disease (AD) diagnosis. The Caregiver's Reactions and Experience (CARE) study, an IDEAS supplement, aimed to understand experiences of PET scan recipients and their care ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · March 2024
BACKGROUND: The Imaging Dementia Evidence for Amyloid Scanning (IDEAS) study reports that amyloid PET scans help providers diagnose and manage Alzheimer's disease and related dementias (ADRD). Using CARE-IDEAS, an IDEAS supplemental study, we examined the ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · February 2024
The NIH Pragmatic Trials Collaboratory supports the design and conduct of 27 embedded pragmatic clinical trials, and many of the studies collect patient reported outcome measures as primary or secondary outcomes. Study teams have encountered challenges in ...
Full textLink to itemCite
Journal ArticleJ Alzheimers Dis · 2024
BACKGROUND: Elevated amyloid-β (Aβ) on positron emission tomography (PET) scan is used to aid diagnosis of Alzheimer's disease (AD), but many prior studies have focused on patients with a typical AD phenotype such as amnestic mild cognitive impairment (MCI ...
Full textLink to itemCite
Journal ArticlePLoS One · 2024
COVID-19 increased the prevalence of clinically significant anxiety in the United States. To investigate contributing factors we analyzed anxiety, reported online via monthly Generalized Anxiety Disorders-7 (GAD-7) surveys between April 2020 and May 2022, ...
Full textLink to itemCite
Journal ArticleRes Gerontol Nurs · 2024
PURPOSE: To understand nursing home workers' experience during the coronavirus disease 2019 (COVID-19) pandemic and investigate the prevalence of health-related quality of life, emotional distress, job satisfaction, and the impact of the pandemic. METHOD: ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 10, 2023
Background Cardiovascular disease (CVD) disproportionately affects Black adults. Greater social networks (SNs), or social connectedness, may lower the risk of CVD events. This study determined the association of SNs and incident CVD and tested mediation by ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · October 1, 2023
Sacubitril/valsartan improves outcomes in patients with heart failure with reduced ejection fraction (HFrEF) compared with angiotensin-converting enzyme inhibitors (ACEis). However, data on postdischarge outcomes in renin-angiotensin system inhibitor (RASi ...
Full textLink to itemCite
Journal ArticleJMIR Med Inform · August 22, 2023
BACKGROUND: Throughout the COVID-19 pandemic, many hospitals conducted routine testing of hospitalized patients for SARS-CoV-2 infection upon admission. Some of these patients are admitted for reasons unrelated to COVID-19 and incidentally test positive fo ...
Full textLink to itemCite
Journal ArticleJ Am Med Inform Assoc · August 18, 2023
Embedded pragmatic clinical trials (ePCTs) play a vital role in addressing current population health problems, and their use of electronic health record (EHR) systems promises efficiencies that will increase the speed and volume of relevant and generalizab ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · July 2023
Embedded pragmatic clinical trials (ePCTs) are conducted during routine clinical care and have the potential to increase knowledge about the effectiveness of interventions under real world conditions. However, many pragmatic trials rely on data from the el ...
Full textLink to itemCite
Journal ArticleJMIR Med Inform · June 17, 2023
BACKGROUND: Throughout the COVID-19 pandemic, many hospitals conducted routine testing of hospitalized patients for SARS-CoV-2 infection upon admission. Some of these patients are admitted for reasons unrelated to COVID-19, and incidentally test positive f ...
Full textLink to itemCite
ConferenceAm J Prev Cardiol · June 2023
OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease, yet little is known about Lp(a) testing patterns in real-world practice. The objective of this analysis was to determine how Lp(a) testing is used in clin ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · June 2023
INTRODUCTION: Racial/ethnic disparities exist in many aspects of health care, but data on racial/ethnic disparities for neurodegenerative diseases (NDDs), such as dementia and Parkinson's disease (PD), are limited. METHODS: We used North and South Carolina ...
Full textLink to itemCite
Journal ArticlePrev Med · May 2023
Whether individuals in real-world settings are able to lose weight and improve cardiometabolic risk factors over time is unclear. We aimed to determine the management of and degree of body weight change over 2 years among individuals with overweight or obe ...
Full textLink to itemCite
Journal ArticleJ Hypertens · May 1, 2023
OBJECTIVE: We aimed to characterize seasonal variation in US population-based blood pressure (BP) control and BP-related metrics and evaluate the association between outdoor temperature and BP control variation. METHODS: We queried electronic health record ...
Full textLink to itemCite
Journal ArticleMayo Clin Proc · May 2023
OBJECTIVE: To explore trends in blood pressure (BP) control before and during the COVID-19 pandemic. PATIENTS AND METHODS: Health systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory S ...
Full textLink to itemCite
ConferenceInt J Infect Dis · April 2023
OBJECTIVES: To determine whether hydroxychloroquine (HCQ) is safe and effective at preventing COVID-19 infections among health care workers (HCWs). METHODS: In a 1: 1 randomized, placebo-controlled, double-blind, parallel-group, superiority trial at 34 US ...
Full textLink to itemCite
Journal ArticleAm Heart J · April 2023
BACKGROUND: Non-Hispanic Black people in the United States have the highest prevalence of essential hypertension. Unfortunately, clinical trials often underrepresent Black patients. We aim to understand whether trial sponsorship type is associated with rep ...
Full textLink to itemCite
Journal ArticleStroke · April 2023
BACKGROUND: Carotid stenosis is thought to be the primary risk factor for central retinal artery occlusion (CRAO); however, it is not known whether atrial fibrillation (AF)-a cardiac arrhythmia that underlies over 25% of cerebral ischemic strokes-predispos ...
Full textLink to itemCite
Journal ArticlemedRxiv · March 12, 2023
BACKGROUND: Cardiovascular disease (CVD) disproportionately affects African American adults. Greater social networks (SN), or social connectedness, may lower the risk of CVD events. OBJECTIVE: Determine the association of SN and incident CVD and test media ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 7, 2023
Background Uncontrolled blood pressure (BP) remains a leading cause of death in the United States. The American Medical Association developed a quality improvement program to improve BP control, but it is unclear how to efficiently implement this program a ...
Full textLink to itemCite
Journal ArticleAm Heart J · February 2023
Several medications that are proven to reduce cardiovascular events exist for individuals with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease, however they are substantially underused in clinical practice. Clinician, patient, an ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · February 1, 2023
IMPORTANCE: Only modest attention has been paid to the contributions of social determinants of health to atrial fibrillation (AF) risk factors, diagnosis, symptoms, management, and outcomes. The diagnosis of AF provides unique challenges exacerbated by the ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · February 2023
BACKGROUND: Few prospective studies of Long COVID risk factors have been conducted. The purpose of this study was to determine whether sociodemographic factors, lifestyle, or medical history preceding COVID-19 or characteristics of acute severe acute respi ...
Full textLink to itemCite
Journal ArticleAlzheimers Res Ther · January 7, 2023
BACKGROUND: High continuity of care (COC) is associated with better clinical outcomes among older adults. The impact of amyloid-β PET scan on COC among adults with mild cognitive impairment (MCI) or dementia of uncertain etiology is unknown. METHODS: We li ...
Full textLink to itemCite
Journal ArticlePLoS One · 2023
IMPORTANCE: The COVID-19 pandemic stressed the healthcare field, resulting in a worker exodus at the onset and throughout the pandemic and straining healthcare systems. Female healthcare workers face unique challenges that may impact job satisfaction and r ...
Full textLink to itemCite
Journal ArticlePLoS One · 2023
Little is known about the mental health consequences of the COVID-19 pandemic in healthcare workers (HCWs). Past literature has shown that chronic strain caused by pandemics can adversely impact a variety of mental health outcomes in HCWs. There is growing ...
Full textLink to itemCite
Journal ArticleClin Trials · December 2022
BACKGROUND: Despite the extensive use of real-world data for retrospective, observational clinical research, our understanding of how real-world data might increase the efficiency of data collection in patient-level randomized clinical trials is largely un ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · December 1, 2022
IMPORTANCE: Patient-reported health data can facilitate clinical event capture in pragmatic clinical trials. However, few data are available on the fitness for use of patient-reported data in large-scale health research. OBJECTIVE: To evaluate the concorda ...
Full textLink to itemCite
Journal ArticleNurs Res · November 2022
BACKGROUND: Nursing professional organizations and media sources indicated early in the pandemic that the physical and psychological effects of COVID-19 might be distinct and possibly greater in nurses than in other types of healthcare workers (HCWs). OBJE ...
Full textLink to itemCite
Journal ArticleBMC Public Health · October 10, 2022
BACKGROUND: It is increasingly recognized that policies have played a role in both alleviating and exacerbating the health and economic consequences of the COVID-19 pandemic. There has been limited systematic evaluation of variation in U.S. local COVID-19- ...
Full textLink to itemCite
Journal ArticleJAMA Intern Med · October 1, 2022
IMPORTANCE: Self-measured blood pressure (SMBP) with commercially available connected smartphone applications may help patients effectively use SMBP measurements. OBJECTIVE: To determine if enhanced SMBP paired with a connected smartphone application was s ...
Full textLink to itemCite
Journal ArticleJ Palliat Care · July 2022
Background: Discussing advance care planning (ACP) with care partners may be a steppingstone to the completion of advance directives (ADs) for persons with cognitive impairment (PwCIs). Objectives: To examine whether PwCI-reported occurrence of and PwCI-ca ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · June 2022
BACKGROUND: Moral injury has primarily been studied in combat veterans but might also affect healthcare workers (HCWs) due to the COVID-19 pandemic. OBJECTIVE: To compare patterns of potential moral injury (PMI) between post-9/11 military combat veterans a ...
Full textLink to itemCite
Journal ArticleTrials · May 21, 2022
BACKGROUND: The COVID-19 pandemic has considerably disrupted nearly all aspects of daily life, including healthcare delivery and clinical research. Because pragmatic clinical trials are often embedded within healthcare delivery systems, they may be at high ...
Full textLink to itemCite
Journal ArticleJ Am Med Inform Assoc · April 13, 2022
OBJECTIVE: To empirically explore how pragmatic clinical trials (PCTs) that used real-world data (RWD) assessed study-specific fitness-for-use. METHODS: We conducted interviews and surveys with PCT teams who used electronic health record (EHR) data to asce ...
Full textLink to itemCite
Journal ArticleBMC cardiovascular disorders · April 2022
BackgroundLeft ventricular structure and function abnormalities may be an early marker of cardiomyopathy among African Americans with diabetes (DM) even in the absence of coronary artery disease (CAD), arrhythmia, valvular heart disease and end-st ...
Full textCite
Journal ArticleERJ Open Res · April 2022
BACKGROUND: An understanding of the experience of patients with progressive fibrosing interstitial lung disease (PF-ILD) is needed to select appropriate patient-reported outcome measures (PROMs) to evaluate treatment effect in clinical trials. METHODS: A s ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · March 2022
Background Associations between depression, incident heart failure (HF), and mortality are well documented in predominately White samples. Yet, there are sparse data from racial minorities, including those who are women, and depression is underrecognized a ...
Full textOpen AccessLink to itemCite
Journal ArticleEClinicalMedicine · March 2022
BACKGROUND: The extent to which healthcare worker (HCWs) experiences during the COVID-19 pandemic vary by race or ethnicity after adjustment for confounding factors is not currently known. METHODS: We performed an observational prospective cohort study of ...
Full textLink to itemCite
Journal ArticleAm Heart J · February 2022
BACKGROUND: As the prevalence of atrial fibrillation (AF) increases, a greater understanding of the costs associated with AF care is required. While individuals with greater arrhythmic burden may interact with the health system more frequently, the relatio ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · February 2022
BACKGROUND: Ethical responsibilities for monitoring and responding to signals of behavioral and mental health risk (such as suicidal ideation, opioid use disorder, or depression) in general clinical research have been described; however, pragmatic clinical ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · February 2022
BACKGROUND: Whether the amount of atrial fibrillation (AF) patients experience conveys important prognostic information beyond that provided by the diagnosis of AF is uncertain. The study objective was to assess the dose-response relationship between devic ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · February 1, 2022
IMPORTANCE: Based on contemporary estimates in the US, evidence-based therapies for cardiovascular risk reduction are generally underused among patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). OBJECTIVE: To determine the us ...
Full textLink to itemCite
Journal ArticleAm Heart J Plus · January 2022
SARS-CoV-2 accesses host cells via angiotensin-converting enzyme-2, which is also affected by commonly used angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), raising concerns that ACEI or ARB exposure may portend di ...
Full textLink to itemCite
Journal ArticlePLoS One · 2022
BACKGROUND: Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. METHODS: The Jackson Heart Study (JHS) enrolled 5,306 African-American ...
Full textLink to itemCite
Journal ArticleJ Alzheimers Dis · 2022
BACKGROUND: Diagnostic tests, such as amyloid-β positron emission tomography (PET) scans, can increase appropriate therapeutic management for the underlying causes of cognitive decline. To evaluate the full utility of this diagnostic tool, information is n ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · December 2021
OBJECTIVES: The authors sought to investigate associations between sacubitril/valsartan adherence and clinical outcomes after hospitalization for heart failure with reduced ejection fraction (HFrEF). BACKGROUND: Sacubitril/valsartan improves outcomes in HF ...
Full textLink to itemCite
Journal ArticleJ Am Med Inform Assoc · November 25, 2021
OBJECTIVE: We identified challenges and solutions to using electronic health record (EHR) systems for the design and conduct of pragmatic research. MATERIALS AND METHODS: Since 2012, the Health Care Systems Research Collaboratory has served as the resource ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 2, 2021
Background The National Patient-Centered Clinical Research Network Blood Pressure Control Laboratory Surveillance System was established to identify opportunities for blood pressure (BP) control improvement and to provide a mechanism for tracking improveme ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · October 2021
BACKGROUND: The SARS CoV-2 virus has caused one of the deadliest pandemics in recent history, resulting in over 170 million deaths and global economic disruption. There remains an urgent need for clinical trials to test therapies for treatment and preventi ...
Full textOpen AccessLink to itemCite
Journal ArticleStroke Vasc Neurol · September 2021
BACKGROUND AND PURPOSE: Depression is common after stroke and is often treated with antidepressant medications (AD). ADs have also been hypothesised to improve stroke recovery, although recent randomised trials were neutral. We investigated the patterns of ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · August 17, 2021
Background Sacubitril/Valsartan has been highly efficacious in randomized trials of heart failure with reduced ejection fraction (HFrEF). However, the effectiveness of sacubitril/valsartan in older patients hospitalized for HFrEF in real-world US practice ...
Full textLink to itemCite
Journal ArticleClin Trials · August 2021
BACKGROUND: Research participant engagement, which we define as recruitment and retention in clinical trials, is a costly and challenging issue in clinical research. Research teams have leveraged a variety of strategies to increase research participant eng ...
Full textLink to itemCite
Journal ArticleJ Card Fail · August 2021
BACKGROUND: We investigated associations between timing of sacubitril/valsartan initiation and postdischarge adherence among patients hospitalized for heart failure with reduced ejection fraction (HFrEF). Clinical trials support initiation of sacubitril/va ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · July 20, 2021
Background Visceral adipose tissue (VAT) is associated with incident heart failure (HF) and HF with preserved ejection fraction, yet it is unknown how pericardial and abdominal adiposity affect HF and mortality risks in Black individuals. We examined the a ...
Full textLink to itemCite
Journal ArticleTrials · July 19, 2021
BACKGROUND: The electronic health record (EHR) contains a wealth of clinical data that may be used to streamline the identification of potential clinical trial participants. However, there is little empirical information on site-level facilitators of and b ...
Full textLink to itemCite
Journal ArticleCirculation · July 6, 2021
Multiple sodium glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have been shown to impart significant cardiovascular and kidney benefits, but are underused in clinical practice. Both SGLT-2i and GLP-1RA ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · May 2021
BACKGROUND: Atrial fibrillation (AF) and heart failure (HF) often accompany one another, and each is independently associated with poor outcomes. However, the association between AF burden and outcomes is poorly understood. OBJECTIVE: The purpose of this s ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · May 2021
BACKGROUND: The HERO registry was established to support research on the impact of the COVID-19 pandemic on US healthcare workers. OBJECTIVE: Describe the COVID-19 pandemic experiences of and effects on individuals participating in the HERO registry. DESIG ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · April 6, 2021
Background Although Black adults are more likely to die from coronary heart disease (CHD) compared with White adults, few studies have examined the relationship between cigarette smoking and CHD risk among Black adults. We evaluated the relationship betwee ...
Full textLink to itemCite
Journal ArticleJ Pediatr · February 2021
OBJECTIVE: To describe enrollment characteristics of youth in the Cascade Screening for Awareness and Detection of FH Registry. STUDY DESIGN: This is a cross-sectional analysis of 493 participants aged <18 years with heterozygous familial hypercholesterole ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · January 19, 2021
Background Evidence-based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Methods and Results Pharmacy and med ...
Full textLink to itemCite
Journal ArticleLaryngoscope · December 2020
OBJECTIVES: To evaluate the relationships among the overall cardiovascular health scoring tool, Life's Simple 7 (LS7), and hearing in an African-American cardiovascular study cohort. METHODS: Using the Jackson Heart Study's cohort of African Americans, the ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2020
BACKGROUND: In PARADIGM-HF, sacubitril/valsartan improved quality of life (QOL) versus enalapril in heart failure with reduced ejection fraction (HFrEF), yet limited data are available regarding QOL changes after sacubitril/valsartan initiation in routine ...
Full textLink to itemCite
Journal ArticleSleep Med · December 2020
BACKGROUND: Suboptimal sleep, including insufficient/long sleep duration and poor sleep quality, is a risk factor for cardiovascular disease (CVD) common but there is little information among African Americans, a group with a disproportionate CVD burden. T ...
Full textLink to itemCite
Journal ArticleEur Heart J Qual Care Clin Outcomes · October 1, 2020
AIMS: To determine the extent of shared decision-making (SDM), during selection of oral anticoagulant (OAC) and rhythm control treatments, in patients with newly diagnosed atrial fibrillation (AF). METHODS AND RESULTS: We evaluated survey data from 1006 pa ...
Full textLink to itemCite
Journal ArticlePharmacol Res Perspect · October 2020
We used electronic medical record (EMR) data in the National Patient-Centered Clinical Research Network (PCORnet) to characterize "real-world" prescription patterns of Type 2 diabetes (T2D) medications. We identified a retrospective cohort of 613,203 adult ...
Full textLink to itemCite
Journal ArticleMed Care · September 2020
BACKGROUND: The CAregiver Perceptions About CommunIcaTion with Clinical Team members (CAPACITY) instrument measures how care partners perceive themselves to be supported by the patient's health care team and their experiences communicating with the team. O ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · August 1, 2020
IMPORTANCE: Clinical and economic consequences of statin treatment guidelines supplemented by targeted coronary artery calcium (CAC) assessment have not been evaluated in African American individuals, who are at increased risk for atherosclerotic cardiovas ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · July 2020
Stroke is one of the leading causes of morbidity and mortality in the United States. While age-adjusted stroke mortality was falling, it has leveled off in recent years due in part to advances in medical technology, health care options, and population heal ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · July 2020
In spring 2018, the American Heart Association convened the Value in Healthcare Summit to begin an important conversation about the challenges patients with cardiovascular disease face in accessing and deriving quality and value from the healthcare system. ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · June 16, 2020
Background Blacks are disproportionately affected by stroke compared with whites; however, less is known about the relationship between stroke and cigarette smoking in blacks. Therefore, we evaluated the relationship between cigarette smoking and all incid ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · May 5, 2020
Background Goal-striving stress (GSS), the stress from striving for goals, is associated with poor health. Less is known about its association with cardiovascular disease (CVD). Methods and Results We used data from the JHS (Jackson Heart Study), a study o ...
Full textOpen AccessLink to itemCite
Journal ArticleChest · May 2020
BACKGROUND: Limited data are available on the association between clinically measured disease severity markers and quality of life (QOL) in idiopathic pulmonary fibrosis (IPF). The study examined the associations between objective disease severity metrics ...
Full textLink to itemCite
Journal ArticleJ Am Med Inform Assoc · April 1, 2020
Pragmatic clinical trials often entail the use of electronic health record (EHR) and claims data, but bias and quality issues associated with these data can limit their fitness for research purposes particularly for study end points. Patient-reported healt ...
Full textOpen AccessLink to itemCite
Journal ArticleJAMA Cardiol · March 1, 2020
IMPORTANCE: There are major gaps in use of guideline-directed medical therapy (GDMT) for patients with heart failure (HF). Patient-reported data outlining patient goals and preferences associated with GDMT are not available. OBJECTIVE: To survey patients w ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · March 2020
BACKGROUND: Uncontrolled blood pressure (BP) is a leading preventable cause of death that remains common in the US population despite the availability of effective medications. New technology and program innovation has high potential to improve BP but may ...
Full textLink to itemCite
Journal ArticleMed Care Res Rev · December 2019
Despite the important role that family caregivers play managing the care of persons with complex health needs, little is known about how caregivers perceive themselves to be recognized and valued by health care professionals. Our objective was to develop a ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · December 2019
BACKGROUND: Post-stroke care delivery may be affected by provider participation in Medicare Shared Savings Program (MSSP) Accountable Care Organizations (ACOs) through systematic changes to discharge planning, care coordination, and transitional care. OBJE ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · December 2019
OBJECTIVES: This study sought to describe clinical outcomes among patients with atrial fibrillation (AF) and contraindications to oral anticoagulation (OAC). BACKGROUND: Treatment with OAC prevents stroke and death in patients with AF, but may be contraind ...
Full textLink to itemCite
Journal ArticlePsychoneuroendocrinology · November 2019
African Americans are at heightened risk for coronary heart disease (CHD), with biologic pathways poorly understood. We examined the role of allostatic load (AL) in the association of depressive symptoms with incident CHD among 2,670 African American men a ...
Full textLink to itemCite
Journal ArticleJAMA Neurol · October 1, 2019
IMPORTANCE: Current guidelines recommend direct oral anticoagulants (DOACs) over warfarin for stroke prevention in patients with atrial fibrillation (AF) who are at high risk. Despite demonstrated efficacy in clinical trials, real-world data of DOACs vs wa ...
Full textOpen AccessLink to itemCite
Journal ArticleAtherosclerosis · October 2019
BACKGROUND AND AIMS: There are limited data from the US on outcomes of patients in specialty care for familial hypercholesterolemia (FH). METHODS: CASCADE FH Registry data were analyzed to assess longitudinal changes in medication usage, in low density lip ...
Full textLink to itemCite
Journal ArticleGlob Heart · September 2019
BACKGROUND: Data demonstrate a positive relationship between socioeconomic status (SES) and cardiovascular health (CVH). OBJECTIVE: To assess the association between individual- and neighborhood-level SES and CVH among participants of the JHS (Jackson Hear ...
Full textLink to itemCite
Journal ArticleBMJ Open · August 1, 2019
OBJECTIVES: To identify if maternal educational attainment is a prognostic factor for gestational weight gain (GWG), and to determine the differential effects of lifestyle interventions (diet based, physical activity based or mixed approach) on GWG, strati ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · July 2019
OBJECTIVES: Palliative care services have the potential to improve the quality of end-of-life care and reduce cost. Services such as the Medicare hospice benefit, however, are often underutilized among stroke patients with a poor prognosis. We tested the h ...
Full textLink to itemCite
Journal ArticleInt J Med Inform · July 2019
OBJECTIVE: To examine the patient perspective on the risks and benefits of linking existing data sources for research. MATERIALS AND METHODS: Between December 2015 and February 2016, we fielded a questionnaire in PatientsLikeMe, an online patient community ...
Full textLink to itemCite
Journal ArticleEur Heart J · June 14, 2019
Much of medical risk prediction involves externally derived prediction equations, nomograms, and point-based risk scores. These settings are vulnerable to misleading findings of incremental value based on versions of the net reclassification index (NRI) in ...
Full textLink to itemCite
Journal ArticleMed Care Res Rev · June 2019
Since 2010, more than 900 accountable care organizations (ACOs) have formed payment contracts with public and private insurers in the United States; however, there has not been a systematic evaluation of the evidence studying impacts of ACOs on care and ou ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2019
BACKGROUND: Emerging data suggest that neck circumference (NC) is associated with cardiometabolic risk factors. Limited research is available regarding the association between NC and cardiovascular outcomes in African Americans. METHODS: Using data from th ...
Full textLink to itemCite
Journal ArticleRespir Res · May 30, 2019
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a variable clinical course and high mortality. We used data from a large national US registry of patients with IPF to investigate relationships between patient characteristics, i ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 21, 2019
BACKGROUND: Primary prevention strategies to mitigate the burden of heart failure (HF) are urgently needed. However, no validated risk prediction tools are currently in use. OBJECTIVES: This study sought to derive 10-year risk equations of developing incid ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · May 2019
Background The Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire has recently been validated to measure the impact of atrial fibrillation on quality of life, but a clinically important difference in AFEQT score has not been well defined. ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 5, 2019
Background The angiotensin-receptor/neprilysin inhibitor ( ARNI ) sacubitril/valsartan reduces hospitalization and mortality for patients with heart failure with reduced ejection fraction. However, adoption of ARNI into clinical practice has been slow. Fac ...
Full textLink to itemCite
Journal ArticleInt J Cardiol · January 1, 2019
BACKGROUND: Renal function has been associated with an increased stroke risk in patients with atrial fibrillation (AF). However, whether renal function incrementally adds to risk prediction in both anticoagulated and non-anticoagulated patients with AF is ...
Full textLink to itemCite
Journal ArticleClin Cardiol · September 2018
BACKGROUND: Comorbid condition and hospital risk-adjusted outcomes prevalence were compared based on clinical registry vs administrative claims data. HYPOTHESIS: Risk-adjusted outcomes will vary depending on the source of comorbidity data used. METHODS: Cl ...
Full textLink to itemCite
Journal ArticleCirculation · August 28, 2018
BACKGROUND: Bleeding is commonly cited as a reason for stopping oral anticoagulants (OACs). Whether minor bleeding events (nuisance bleeding, NB) in patients with atrial fibrillation on OACs are associated with OAC discontinuation, major bleeding, and stro ...
Full textLink to itemCite
Journal ArticleJ Palliat Med · August 2018
BACKGROUND: Use of the Medicare hospice benefit has been associated with high-quality care at the end of life, and hospice length of use in particular has been used as a proxy for appropriate timing of hospice enrollment. Quantile regression has been under ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · July 15, 2018
Conflicting data exist regarding the associations of early repolarization (ER) with electrocardiogram (ECG) and clinical outcomes in blacks. We examined the association of ER defined by J point elevation (JPE) and all-cause mortality, and heart failure (HF ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · June 12, 2018
BACKGROUND: Surveys of patients with cardiovascular disease have suggested that "home-time"-being alive and out of any health care institution-is a prioritized outcome. This novel measure has not been studied among patients with heart failure (HF). OBJECTI ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · June 9, 2018
BACKGROUND: Oral anticoagulation (OAC) reduces stroke risk in atrial fibrillation, but bleeding is a frequent side effect. The decision to discontinue or modify medication regimens in response to a bleeding event may differ according to bleeding site and s ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2018
BACKGROUND: On May 20, 2016, US professional organizations in cardiology published joint treatment guidelines recommending the use of angiotensin-receptor neprilysin inhibitor (ARNI) for eligible patients with heart failure with reduced ejection fraction ( ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2018
BACKGROUND: Non-adherence to medications is common and leads to suboptimal outcomes. Non-adherence can be intentional (e.g., deciding to skip dosages) or unintentional (e.g., forgetting), yet few studies have distinguished these reasons. An improved unders ...
Full textLink to itemCite
Journal ArticleLancet · March 3, 2018
BACKGROUND: Intensive antiplatelet therapy with three agents might be more effective than guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. We aimed to compare the safety and efficacy of intensive antiplatelet t ...
Full textLink to itemCite
Journal ArticleHeart · March 2018
OBJECTIVE: To describe self-reported disease understanding for newly diagnosed patients with atrial fibrillation (AF) and assess (1) how disease understanding changes over the first 6 months after diagnosis and (2) the relationship between patient understa ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2018
BACKGROUND: Non-ST-segment elevation myocardial infarction (NSTEMI) comprises the majority of MI worldwide, yet mortality remains high. Management of NSTEMI is relatively delayed and heterogeneous compared with the "time is muscle" approach to ST-segment e ...
Full textLink to itemCite
Journal ArticleAtherosclerosis · December 2017
BACKGROUND AND AIMS: Most familial hypercholesterolemia (FH) patients remain undertreated, and it is unclear what role health disparities may play for FH patients in the US. We sought to describe sex and racial/ethnic disparities in a national registry of ...
Full textLink to itemCite
Journal ArticleEpidemiology · September 2017
BACKGROUND: The Jackson Heart Study (JHS) assesses cardiovascular disease risk factors among African Americans in Jackson, Mississippi. Whether characteristics of JHS participants differ from those of a broader African American population are unknown. METH ...
Full textLink to itemCite
Journal ArticleCirculation · August 29, 2017
BACKGROUND: Data from before the 2000s indicate that the majority of incident cardiovascular disease (CVD) events occur among US adults with systolic and diastolic blood pressure (SBP/DBP) ≥140/90 mm Hg. Over the past several decades, BP has declined and h ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2017
BACKGROUND: Several non-vitamin K antagonist oral anticoagulant (NOAC) alternatives to warfarin are available for stroke prevention in atrial fibrillation (AF). We aimed to describe the factors associated with selection of NOACs versus warfarin in patients ...
Full textLink to itemCite
Journal ArticleJ Clin Hypertens (Greenwich) · May 2017
UNLABELLED: Single-site, intensive, community-based blood pressure (BP) intervention programs have led to BP improvements. The authors examined the American Heart Association's Check. Change. CONTROL: (CCC) program (4069 patients/18 cities) to determine wh ...
Full textLink to itemCite
Journal ArticleMayo Clin Proc · May 2017
OBJECTIVE: To assess the associations of perceived discrimination and cardiovascular (CV) outcomes in African Americans (AAs) in the Jackson Heart Study. PATIENTS AND METHODS: In 5085 AAs free of clinical CV disease at baseline enrolled in the Jackson Hear ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · May 2017
BACKGROUND: Use of the CHA2DS2-VASc score instead of the CHADS2 score for thromboembolic risk stratification and initiation of oral anticoagulation (OAC) was recommended in the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Soc ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · April 2017
OBJECTIVES: The aim of this study was to assess the prevalence and variation in angiotensin receptor/neprilysin inhibitor (ARNI) prescription among a real-world population with heart failure with reduced ejection fraction (HFrEF). BACKGROUND: The U.S. Food ...
Full textLink to itemCite
Journal ArticleJAMA · March 14, 2017
IMPORTANCE: Antithrombotic therapies are known to prevent stroke for patients with atrial fibrillation (AF) but are often underused in community practice. OBJECTIVES: To examine the prevalence of patients with acute ischemic stroke with known history of AF ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Cardiol · February 15, 2017
The Long-term Effect of Goal Directed Weight Management in an Atrial Fibrillation Cohort: A Long-term Follow-up Study (LEGACY) demonstrated that weight reduction in a cohort of Australian patients with atrial fibrillation (AF) resulted in a reduction in AF ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 3, 2017
BACKGROUND: Healthcare resources vary geographically, but associations between hospital-based resources and acute stroke quality and outcomes remain unclear. METHODS AND RESULTS: Using Get With The Guidelines-Stroke and Dartmouth Atlas of Health Care data, ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · February 1, 2017
IMPORTANCE: Increased resting heart rate is associated with worse outcomes in studies of mostly white populations, but its significance is not well established in African Americans persons whose cardiac comorbidities and structural abnormalities differ. OB ...
Full textLink to itemCite
Journal ArticleASAIO J · 2017
Left ventricular assist device (LVAD) therapy unloads the failing heart but exposes the human body to unique pathophysiologic demands such as continuous blood flow and complete univentricular support, which are associated with increased risk of adverse cli ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · December 7, 2016
BACKGROUND: In 2014, new hypertension guidelines liberalized blood pressure goals for persons 60 years and older. Little is known about the implications for blacks. METHODS AND RESULTS: Using data from 2000 through 2011 for 5280 participants in the Jackson ...
Full textLink to itemCite
Journal ArticleStroke · October 2016
BACKGROUND AND PURPOSE: Stroke survivors identify home-time as a high-priority outcome; there are limited data on factors influencing home-time and home-time variability among discharging hospitals. METHODS: We ascertained home-time (ie, time alive out of ...
Full textLink to itemCite
Journal ArticleJ Card Fail · August 2016
BACKGROUND: Higher rates of obesity and heart failure have been observed in African Americans, but associations with mortality are not well-described. We examined intermediate and long-term clinical implications of obesity in African Americans and associat ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2016
BACKGROUND: Evidence from existing cohort studies supports the prediction of incident coronary heart disease and stroke using 10-year cardiovascular disease (CVD) risk scores and the American Heart Association/American Stroke Association's cardiovascular h ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Genet · June 2016
BACKGROUND: Cardiovascular disease burden and treatment patterns among patients with familial hypercholesterolemia (FH) in the United States remain poorly described. In 2013, the FH Foundation launched the Cascade Screening for Awareness and Detection (CAS ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · May 4, 2016
BACKGROUND: Whereas insurance status has been previously associated with care patterns, little is currently known about the association between Medicaid insurance and the clinical characteristics, treatment, or outcomes of patients with atrial fibrillation ...
Full textOpen AccessLink to itemCite
Journal ArticleStroke · March 2016
BACKGROUND AND PURPOSE: Stroke survivors have identified home-time as a meaningful outcome. We evaluated home-time as a patient-centered outcome in Medicare beneficiaries with ischemic stroke in comparison with modified Rankin Scale (mRS) score at 90 days ...
Full textLink to itemCite
Journal ArticleAm Heart J · March 2016
BACKGROUND: Clinical trial evidence suggests that statin therapy reduces adverse clinical events and provides even greater benefit at high-intensity doses in coronary artery disease (CAD) patients, yet few studies have examined this in clinical practice. M ...
Full textLink to itemCite
Journal ArticleCirculation · March 1, 2016
Randomized, clinical trials are commonly regarded as the highest level of evidence to support clinical decisions. Good Clinical Practice guidelines have been constructed to provide an ethical and scientific quality standard for trials that involve human su ...
Full textLink to itemCite
Journal ArticleBMJ Open Respir Res · 2016
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterised by progressive loss of lung function. Its clinical course is variable but ultimately fatal. There is a need for a multicentre patient registry incorporatin ...
Full textLink to itemCite
Journal ArticleJ Clin Lipidol · 2016
BACKGROUND: In the US familial hypercholesterolemia (FH), patients are underidentified, despite an estimated prevalence of 1:200 to 1:500. Criteria to identify FH patients include Simon Broome, Dutch Lipid Clinic Network (DLCN), or Make Early Diagnosis to ...
Full textLink to itemCite
Journal ArticleEur Heart J · December 7, 2015
BACKGROUND: Therapeutic decisions in atrial fibrillation (AF) are often influenced by assessment of bleeding risk. However, existing bleeding risk scores have limitations. OBJECTIVES: We sought to develop and validate a novel bleeding risk score using rout ...
Full textOpen AccessLink to itemCite
Journal ArticleEuropean heart journal · December 7, 2015
BACKGROUND: Therapeutic decisions in atrial fibrillation (AF) are often influenced by assessment of bleeding risk. However, existing bleeding risk scores have limitations. ...
Full textCite
Journal ArticleCirc Cardiovasc Qual Outcomes · November 2015
BACKGROUND: Most studies of depression and cardiovascular risk have been conducted in white populations. We investigated this association in a community-based cohort of blacks. METHODS AND RESULTS: We used data from the Jackson Heart Study to investigate a ...
Full textLink to itemCite
Journal ArticleCirculation · October 13, 2015
BACKGROUND: In patients with ischemic stroke, data on the real-world effectiveness of statin therapy for clinical and patient-centered outcomes are needed to better inform shared decision making. METHODS AND RESULTS: Patient-Centered Research Into Outcomes ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · October 2015
BACKGROUND: Patients with transient ischemic attack (TIA) are at increased risk for ischemic stroke. We derived a prediction rule for 1-year ischemic stroke risk post-TIA, examining estimated risk, receipt of inpatient quality of care measures for TIA, and ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 2015
BACKGROUND: Prior work has demonstrated that adherence to American College of Cardiology/American Heart Association guideline recommendations is associated with decreased in-hospital mortality in non-ST-segment elevation myocardial infarction (NSTEMI) pati ...
Full textLink to itemCite
Journal ArticleBMJ · July 31, 2015
OBJECTIVE: To examine the association between warfarin treatment and longitudinal outcomes after ischemic stroke in patients with atrial fibrillation in community practice. DESIGN: Observational study. SETTING: Hospitals (n = 1487) participating in the Get ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Heart Fail · July 2015
BACKGROUND: Current heart failure (HF) risk prediction models do not consider how individual patient assessments occur in incremental steps; furthermore, each additional diagnostic evaluation may add cost, complexity, and potential morbidity. METHODS AND R ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2015
BACKGROUND: Stroke is common and costly, annually depriving the lives and well-being of 800,000 Americans. Despite demonstrated efficacy in clinical trials, questions remain about the safety and clinical effectiveness of various treatment options given pat ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2015
BACKGROUND: Statins reduce mortality after acute myocardial infarction, but up to half of patients discontinue statin use within 1 year of therapy initiation. Although cost may influence medication adherence, it is unknown whether use of generic versus bra ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · June 15, 2015
Elevated low-density lipoprotein cholesterol (LDL-C) is associated with increased risk of myocardial infarction and is a target for disease prevention. The association between initial LDL-C and statin treatment in patients with non-ST-segment elevation myo ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · March 2015
BACKGROUND: QRS prolongation is associated with adverse outcomes in mostly white populations, but its clinical significance is not well established for other groups. We investigated the association between QRS duration and mortality in African Americans. M ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC Heart Fail · January 2015
OBJECTIVES: The purpose of this study was to examine changes in a broad panel of biomarkers following left ventricular assist device (LVAD) support in advanced heart failure (HF). BACKGROUND: LVAD therapy mechanically unloads the failing heart and may resu ...
Full textLink to itemCite
Journal ArticlePatient Educ Couns · December 2014
OBJECTIVE: Patient-centered approaches to improving medication adherence hold promise, but evidence of their effectiveness is unclear. This review reports the current state of scientific research around interventions to improve medication management throug ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2014
Familial hypercholesterolemia (FH) is a genetic disease characterized by substantial elevations of low-density lipoprotein cholesterol, unrelated to diet or lifestyle. Untreated FH patients have 20 times the risk of developing coronary artery disease, comp ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · October 28, 2014
BACKGROUND: Classification of chronic heart failure (HF) is on the basis of criteria that may not adequately capture disease heterogeneity. Improved phenotyping may help inform research and therapeutic strategies. OBJECTIVES: This study used cluster analys ...
Full textLink to itemCite
Journal ArticleAm Heart J · October 2014
BACKGROUND: Warfarin reduces thromboembolic risks in atrial fibrillation (AF), but therapeutic durability remains a concern. METHODS: We used clinical data from ORBIT-AF, a nationwide outpatient AF registry conducted at 176 sites with follow-up data at 6 a ...
Full textLink to itemCite
Journal ArticleAm Heart J · May 2014
BACKGROUND: Prior studies have found that academic hospitals provide more consistent use of guideline-recommended therapies in patients with non-ST-segment myocardial infarction (NSTEMI) compared with nonacademic centers, yet it is unclear whether these ca ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · April 10, 2014
BACKGROUND: Organized stroke care is associated with improved outcomes. Data are limited on differences in changes in the quality of acute stroke care at The Joint Commission-certified Primary Stroke Centers (PSCs) versus non-PSCs over time. METHODS AND RE ...
Full textLink to itemCite
Journal ArticleAm Heart J · April 2014
BACKGROUND: Oral anticoagulation (OAC) therapy reduces the risk of thromboembolic events associated with atrial fibrillation (AF), yet a substantial proportion of patients with AF are not prescribed OAC. The aim of this study is to describe the frequencies ...
Full textLink to itemCite
Journal ArticleAm Heart J · March 2014
BACKGROUND: Familial hypercholesterolemia (FH) is a hereditary condition caused by various genetic mutations that lead to significantly elevated low-density lipoprotein cholesterol levels and resulting in a 20-fold increased lifetime risk for premature car ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · January 2014
BACKGROUND: Prior studies have found that obese patients have paradoxically lower in-hospital mortality after non-ST-segment-elevation myocardial infarction than their normal-weight counterparts, yet whether these associations persist long term is unknown. ...
Full textLink to itemCite
Journal ArticleHeart · June 2013
OBJECTIVE: To examine the survival benefit of multiple medical therapies in a large, community-based population of validated myocardial infarction (MI) events. DESIGN: Retrospective observational cohort study. SETTING: Population-based sample of 30 986 def ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · February 1, 2013
Reports from large studies using administrative data sets and event registries have characterized recent temporal trends and treatment patterns for acute myocardial infarction. However, few were population based, and fewer examined differences in patterns ...
Full textLink to itemCite
Journal ArticleJ Stroke Cerebrovasc Dis · October 2012
BACKGROUND: Tissue plasminogen activator therapy (t-PA) is associated with improved neurologic outcomes and reduced disability from ischemic stroke. The current guidelines stipulate that patients receive t-PA within 3 hours of symptom onset. However, actua ...
Full textLink to itemCite
Journal ArticleN C Med J · 2012
The North Carolina Stroke Care Collaborative is a stroke care quality-improvement (QI) program that provides performance data to hospitals continuously, allowing for rapid feedback and for development of QI initiatives. Between 2005 and 2012, 89,413 stroke ...
Link to itemCite
Journal ArticleStroke · August 2011
BACKGROUND AND PURPOSE: Individuals with stroke-like symptoms are recommended to receive rapid diagnostic evaluation. Emergency medical services (EMS) transport, compared with private modes, and hospital notification before arrival may reduce delays in eva ...
Full textLink to itemCite
Journal ArticleStroke Res Treat · 2011
Background. Recent studies report that acute stroke patients who present to the hospital on weekends have higher rates of 28-day mortality than similar patients who arrive during the week. However, how this association is related to clinical presentation a ...
Full textLink to itemCite
Journal ArticleAcad Emerg Med · December 2010
OBJECTIVES: regionalization of stroke care, including diversion to stroke centers, requires that emergency medical services (EMS) systems accurately identify acute stroke patients. A barrier to evaluating and improving EMS stroke patient identification is ...
Full textLink to itemCite